Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000272581 | SCV000329918 | pathogenic | not provided | 2023-08-28 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25592411, 34272103, 25356899, 26790960, 26481852, 29445477, 28932395, 26173968, 25263061, 24847269, 24621584, 23687123, 23435086, 20562859, 23176820, 29981852, 31487502, 32382396, 33391346, 34374989) |
Ambry Genetics | RCV000624584 | SCV000740993 | pathogenic | Inborn genetic diseases | 2015-08-20 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000705613 | SCV000834618 | pathogenic | Neurodegeneration with brain iron accumulation 5 | 2024-04-03 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg7*) in the WDR45 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in WDR45 are known to be pathogenic (PMID: 23176820, 24368176, 24621584, 25744623, 26790960, 27030146, 27652284, 28554332). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with neurodegeneration with brain iron accumulation (PMID: 23176820, 25356899). ClinVar contains an entry for this variant (Variation ID: 280098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. |
Ce |
RCV000272581 | SCV001247589 | pathogenic | not provided | 2018-10-01 | criteria provided, single submitter | clinical testing | |
Génétique des Maladies du Développement, |
RCV001255400 | SCV001431800 | pathogenic | Global developmental delay | 2019-11-01 | criteria provided, single submitter | clinical testing | |
3billion, |
RCV000705613 | SCV002012095 | pathogenic | Neurodegeneration with brain iron accumulation 5 | 2021-10-02 | criteria provided, single submitter | clinical testing | Stop-gained (nonsense): predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant (PVS1_VS). The variant was observed as assumed (i.e. paternity and maternity not confirmed) de novoo (3billion dataset, PM6). It is not observed in the gnomAD v2.1.1 dataset (PM2). The variant has been reported multiple times as an established pathogenic variant (ClinVar Id: VCV000280098.14, PMID: 32382396, 31487502). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. |
Molecular Genetics Lab, |
RCV003883145 | SCV004697802 | pathogenic | Neurodegeneration with brain iron accumulation 5; Oculocutaneous albinism type 7 | criteria provided, single submitter | clinical testing | ||
Al Jalila Children’s Genomics Center, |
RCV000705613 | SCV005420677 | pathogenic | Neurodegeneration with brain iron accumulation 5 | 2024-10-04 | criteria provided, single submitter | research | PVS1,PM6,PM2 |